resveratrol has been researched along with Protein Aggregation, Pathological in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Tan, Z; Xiao, G; Yang, X | 1 |
| Du, H; Jiang, X; Liu, S; Ma, F; Ma, M; Xu, H | 1 |
| Chowdhury, SR; Fu, L; Gu, J; Hu, Y; Jiang, F; Lam, C; Lei, S; Lu, D; Tavallaie, MS; Wang, J | 1 |
| Gulyayev, A; Krivykh, E; Masoud, AR; Nurgozhin, T; Saliev, T; Sergazy, S; Umbayev, B; Yessenkyzy, A; Zhanaliyeva, M | 1 |
| Al-Edresi, S; Alsalahat, I; Aojula, H; Freeman, S; Penny, J | 1 |
| Chan, S; Deora, GS; Dighe, SN; Kantham, S; Khabbazi, S; McColl, G; Miles, JA; Parat, MO; Ross, BP; Veliyath, SK | 1 |
| Chang, JC; Chen, HW; Hsieh, M; Li, CC; Lin, WY; Liu, CS; Liu, KL; Wang, TS; Wu, WT; Wu, YL | 1 |
| Chen, J; Wang, N; Wang, W; Yang, L; Zheng, G | 1 |
| Liu, J; Liu, Y; Sun, J; Wei, C; Xie, W; Xu, M; Zhou, H | 1 |
| Ghasemi, A; Meratan, AA; Nemat-Gorgani, M; Shariatizi, S | 1 |
| Chun Ke, P; Davis, TP; Ding, F; Kakinen, A; Nedumpully-Govindan, P; Pilkington, EH | 1 |
| Andrade, S; Coelho, MA; Duarte, A; Fenart, L; Gosselet, F; Loureiro, JA; Neves, AR; Nunes, C; Pereira, MC; Queiroz, JF; Sevin, E | 1 |
1 review(s) available for resveratrol and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.
Topics: Aging; Animals; Apoptosis; Autophagy; Caloric Restriction; Cellular Senescence; Diabetes Mellitus; Dietary Supplements; Healthy Aging; Humans; Longevity; Mitochondria; Neoplasms; Neurodegenerative Diseases; Polyphenols; Protein Aggregation, Pathological; Resveratrol; Sirtuin 1 | 2020 |
11 other study(ies) available for resveratrol and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzylamines; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Stilbenes; Structure-Activity Relationship | 2016 |
Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Carbolines; Cell Line; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological | 2020 |
Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Benzofurans; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; Piperidines; Protein Aggregates; Protein Aggregation, Pathological; Structure-Activity Relationship | 2021 |
Resveratrol-mediated cleavage of amyloid β
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Humans; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Protein Binding; Resveratrol; Tumor Cells, Cultured | 2020 |
Effect of the Biphenyl Neolignan Honokiol on Aβ
Topics: Amyloid beta-Peptides; Animals; Biphenyl Compounds; Caenorhabditis elegans; Catechin; Chelating Agents; Cholinesterase Inhibitors; Drug Stability; Free Radical Scavengers; Humans; Iron; Lignans; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Paralysis; Peptide Fragments; Picrates; Protein Aggregation, Pathological; Protein Multimerization; Resveratrol; Stilbenes | 2017 |
Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway.
Topics: Animals; Antioxidants; Ataxin-3; Autophagy; Caffeic Acids; Cell Line; Disease Models, Animal; Drosophila; Efferent Pathways; Humans; Machado-Joseph Disease; Mutation; Neurons; NF-E2-Related Factor 2; Protein Aggregation, Pathological; Resveratrol; RNA, Small Interfering; Signal Transduction; Transgenes; Up-Regulation | 2018 |
A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Humans; Nanoparticles; PC12 Cells; Protein Aggregates; Protein Aggregation, Pathological; Rats; Reactive Oxygen Species; Resveratrol; Selenium | 2018 |
Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; beta-Cyclodextrins; Blood-Brain Barrier; Camphanes; Cell Line, Tumor; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Synergism; Humans; Mice; Nanoconjugates; Oxidation-Reduction; Porosity; Protein Aggregation, Pathological; Reactive Oxygen Species; Resveratrol; Selenium; Specific Pathogen-Free Organisms | 2019 |
Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols.
Topics: Amyloid; Animals; Antioxidants; Cell Shape; Cell Survival; Cinnamates; Depsides; Drug Evaluation, Preclinical; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Muramidase; PC12 Cells; Protein Aggregation, Pathological; Protein Stability; Protein Structure, Secondary; Rats; Resveratrol; Rosmarinic Acid; Stilbenes | 2015 |
Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition.
Topics: Aspirin; Curcumin; Hydrophobic and Hydrophilic Interactions; Islet Amyloid Polypeptide; Models, Molecular; Molecular Conformation; Nanostructures; Polyphenols; Protein Aggregates; Protein Aggregation, Pathological; Protein Binding; Resveratrol; Stilbenes | 2016 |
Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Drug Compounding; Drug Delivery Systems; Drug Liberation; Grape Seed Extract; Immunoconjugates; Lipids; Nanoparticles; Particle Size; Permeability; Plant Extracts; Protein Aggregates; Protein Aggregation, Pathological; Resveratrol; Stilbenes; Vitis | 2017 |